Latest On Cansortium Inc (CNTMF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-02 06:31 EST | News | Cansortium Inc. (CNTMF) Q4 2022 Earnings Call Transcript | N/A |  |
| 2022-11-30 12:38 EST | News | Cansortium Inc. (CNTMF) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-29 19:50 EST | News | Cansortium GAAP EPS of -$0.02, revenue of $22.1M misses by $2.9M | N/A | |
| 2022-09-11 20:28 EST | News | Cansortium Inc.: The Most Underappreciated Cannabis Company | N/A | |
| 2022-08-30 00:27 EST | News | Cansortium GAAP EPS of -$0.05, revenue of $22.4M | N/A | |
| 2022-08-30 00:27 EST | News | Cansortium Inc. (CNTMF) Q2 2022 Earnings Call Transcript | N/A | |
| 2022-06-06 15:27 EST | News | Cansortium: Investor Meetings Highlight Favorable Turnaround | N/A | |
| 2022-05-03 08:31 EST | News | Cansortium revenue of $16.5M misses by $1M | N/A | |
| 2022-05-03 08:31 EST | News | Cansortium Inc. (CNTMF) CEO Robert Beasley on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2021-12-01 16:26 EST | News | Cansortium Inc. (CNTMF) CEO Robert Beasley on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-12-01 16:26 EST | News | Making The Case For Mid-Tier MSOs (Podcast) | N/A | |
| 2021-12-01 16:26 EST | News | Cansortium Remains On Track To Scale Capacity | N/A | |
| 2021-11-30 19:18 EST | News | Cansortium reports Q3 results | N/A | |
| 2021-08-26 07:37 EST | News | Cansortium Inc.'s (CNTMF) CEO Robert Beasley on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-05-07 22:51 EST | News | Cansortium Inc. (CNTMF) CEO Robert Beasley on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-10 14:03 EST | Analyst Rating | The Analyst Target Price has increased from $0.96 to $1.85. | Buy | |
| 2021-03-03 01:48 EST | News | Cansortium: One Of Few Remaining Florida Cannabis Gems | N/A | |
| 2021-02-26 14:04 EST | Analyst Rating | The Analyst Target Price has increased from $0.95 to $0.96. | Buy | |
| 2021-01-29 22:41 EST | Analyst Rating | The Analyst Target Price has decreased from $0.96 to $0.95. | Neutral | |
| 2021-01-22 22:50 EST | Analyst Rating | The Analyst Target Price has increased from $0.95 to $0.96. | Buy | |
| 2021-01-21 14:55 EST | Analyst Rating | The Analyst Target Price has increased from $0.7 to $0.95. | Buy | |
| 2021-01-15 18:20 EST | Analyst Rating | The Analyst Target Price has decreased from $0.71 to $0.7. | Neutral | |
| 2021-01-08 22:38 EST | Analyst Rating | The Analyst Target Price has increased from $0.7 to $0.71. | Buy | |
| 2020-12-21 21:41 EST | News | Cansortium CFO Marcos Pedreira resigns | N/A | |
| 2020-12-18 06:27 EST | News | Cansortium extends $10M convertible notes | N/A | |
| 2020-12-04 06:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-02 15:15 EST | Analyst Rating | The Analyst Target Price has decreased from $0.83 to $0.7. | Neutral | |
| 2020-11-27 01:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-25 23:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-25 16:13 EST | News | Cansortium Inc. (CNTMF) CEO Robert Beasley on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-23 09:59 EST | News | Cansortium beats on revenue, reiterates FY20 outlook | N/A | |
| 2020-11-06 23:20 EST | Analyst Rating | The Analyst Target Price has increased from $0.82 to $0.83. | Buy | |
| 2020-10-08 21:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-04 15:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-29 20:44 EST | News | Cansortium has a new CEO | N/A | |
| 2020-09-26 16:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-18 20:40 EST | Analyst Rating | The Analyst Target Price has decreased from $0.83 to $0.82. | Neutral | |
| 2020-09-17 09:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-28 19:16 EST | Analyst Rating | The Analyst Target Price has increased from $0.82 to $0.83. | Buy | |
| 2020-08-28 17:25 EST | News | Cansortium reports Q2 results | N/A | |
| 2020-08-27 19:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 12:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 16:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 19:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 12:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 04:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 20:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 08:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 01:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 16:39 EST | Financials | Company financials have been released. | Neutral | |
About Cansortium Inc (CNTMF):
Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. It operates cultivation, processing, and dispensary facilities in Florida and Texas; and a dispensary license in Pennsylvania. The company offers its products in the form of oral drops, capsules, suppositories, topicals, syringes, dried flowers, prerolls, and cartridges. It markets its products under the Fluent brand name. As of December 21, 2020, it operated 24 dispensaries. Cansortium Inc. was founded in 2015 and is headquartered in Miami, Florida.
General
- Name Cansortium Inc
- Symbol CNTMF
- Type Common Stock
- Exchange OTCQB
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Fiscal Year EndDecember
- Web URLhttp://www.cansortium.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 4.4
- Price/Book (Most Recent Quarter) 2.44
- Enterprise Value Revenue 3.45
View More
Financials
- Most Recent Quarter 2020-09-30
- Profit Margin -129%
- Operating Margin -2%
- Return on Equity -66%
- Revenue 47.22 million
- Earnings Per Share -$0.04
- Revenue Per Share $0.24
- Gross Profit 18.06 million
- Quarterly Earnings Growth 93.8%
View More
Highlights
- Market Capitalization 92.06 million
- EBITDA -28693000
- Analyst Target Price $1.85
- Book Value Per Share $0.19
View More
Share Statistics
- Shares Outstanding 105.58 million
- Shares Float 122.56 million
- % Held by Insiders 1300%
- % Held by Institutions 0.29%
View More
Technicals
- 52 Week High $0.92
- 52 Week Low $0.05
- 50 Day Moving Average 0.76
- 200 Day Moving Average 0.76
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Cansortium Inc (CNTMF) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Cansortium Inc (CNTMF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-09-30 | $14.31 million | -$0.04 | $0.00 | |
| 2020-06-30 | 2020-09-30 | $N/A | -$0.04 | -$0.02 | -113% |
| 2020-03-31 | 2020-06-30 | $10.16 million | -$0.03 | -$0.02 | -49% |
| 2019-12-31 | 2020-03-31 | $9.51 million | -$0.07 | -$0.02 | -266% |
| 2019-09-30 | 2019-11-29 | $7.39 million | -$0.06 | -$0.01 | -500% |
| 2019-06-30 | 2019-09-30 | $6.09 million | -$0.06 | -$0.01 | -500% |
| 2019-03-31 | 2019-06-30 | $5.53 million | -$0.03 | $0.00 | |
| 2018-12-31 | 2019-03-31 | $4.9 million | -$0.10 | $0.00 | |
| 2018-09-30 | 2018-12-31 | $2.94 million | -$0.13 | $0.00 | |
| 2018-06-30 | 2018-09-30 | $151846 | $0.20 | $0.00 | |
| 2018-03-31 | 2018-06-30 | -$0.01 | $0.00 | ||
| 2017-12-31 | 2018-03-31 | -$0.06 | $0.00 | ||
| 2017-09-30 | 2017-12-31 | -$0.03 | $0.00 |
Cansortium Inc (CNTMF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | -7.37 million | N/A | -11.46 million | -17.67 million | -10.84 million |
| Selling General Administrative | 8.12 million | N/A | 7.15 million | 10.95 million | 7.97 million |
| Gross Profit | 7.74 million | N/A | 11.05 million | 9.38 million | 2.43 million |
| Ebit | -1.39 million | N/A | -5.71 million | -12.03 million | -5.08 million |
| Operating Income | -1.94 million | N/A | 2.4 million | -2.18 million | -8.08 million |
| Income Tax Expense | 1.28 million | 3.31 million | 2.83 million | N/A | 432000 |
| Total Revenue | 14.31 million | N/A | 10.16 million | 9.51 million | 7.39 million |
| Cost of Revenue | 6.57 million | N/A | -888000 | 123000 | 4.95 million |
| Total Other Income Expense Net | -1.55 million | N/A | -10.1 million | -10.47 million | 169000 |
| Net Income From Continuing Operations | -8.65 million | N/A | -14.29 million | -20.13 million | -11.27 million |
| Net Income Applicable to Common Shares | -8.89 million | -5.47 million | -13.91 million | -13.91 million | -11.36 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -1.49 million | N/A | -1.47 million | -5.16 million | -3.83 million |
| Change to Liabilities | -1.28 million | -30000 | 998000 | N/A | -854000 |
| Total Cash Flow from Investing Activities | -1.49 million | -601000 | -1.47 million | N/A | -3.83 million |
| Net Borrowings | -1.04 million | -1.1 million | -1.01 million | N/A | 1.21 million |
| Total Cash Flow from Financial Activities | -1.04 million | N/A | 3.34 million | -10.47 million | 1.21 million |
| Change to Operating Activities | 24000 | -329000 | 69000 | N/A | -5.94 million |
| Change in Cash | -1.13 million | N/A | 2.33 million | -2.49 million | -16.36 million |
| Total Cash from Operating Activities | 1.39 million | 1.8 million | 531000 | 13.15 million | -13.72 million |
| Depreciation | 2.09 million | N/A | 1.99 million | 619000 | 2.84 million |
| Other Cash Flow from Investing Activities | -479000 | -207000 | -339000 | N/A | N/A |
| Change to Inventory | 6.35 million | N/A | 7.65 million | 5.38 million | 711000 |
| Change to Account Receivables | 68000 | N/A | 8000 | -114000 | 53000 |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | 3.05 million | -2.35 million | 2.49 million | N/A | -1.43 million |
| Capital Expenditures | 1.01 million | N/A | 1.13 million | 1.29 million | 3.83 million |
Balance Sheet:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 128.59 million | N/A | 125.09 million | 119.89 million | 77 million |
| Total Stockholder Equity | 38.24 million | N/A | 47.04 million | 47.34 million | 110.09 million |
| Other Current Liabilities | 13.79 million | N/A | 16.61 million | 16.44 million | 9.77 million |
| Total Assets | 166.83 million | N/A | 171.97 million | 167.07 million | 186.54 million |
| Common Stock | 147.85 million | 145.06 million | 144.48 million | 149.32 million | 165.08 million |
| Other Current Assets | 178000 | N/A | 128000 | 54000 | 388000 |
| Retained Earnings | -138.89 million | -130.72 million | -125.29 million | -123.79 million | -64.78 million |
| Other Liabilities | 27.13 million | 27.58 million | 26.82 million | 25.63 million | 1.5 million |
| Other Assets | 390000 | 375000 | 4.5 million | 6.59 million | 320000 |
| Cash | 4.07 million | N/A | 4.85 million | 2.52 million | 5.01 million |
| Total Current Liabilities | 68.04 million | N/A | 39.71 million | 42.04 million | 30.36 million |
| Other Stockholder Equity | 29.29 million | 29.07 million | 27.84 million | 21.8 million | 9.29 million |
| Property, Plant & Equipment | 38.09 million | 38.49 million | 38.84 million | 39.32 million | 45.08 million |
| Total Current Assets | 26.05 million | N/A | 29.89 million | 23.94 million | 21.02 million |
| Long Term Investments | 3.37 million | N/A | 3.24 million | 3.42 million | N/A |
| Net Tangible Assets | -60.7 million | -55.91 million | -52.67 million | -52.76 million | -10.54 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | 12.7 million | N/A | 37.9 million | 31.05 million | 28.76 million |
| Inventory | 15.7 million | N/A | 15.01 million | 10.55 million | 9.54 million |
| Accounts Payable | 4.56 million | N/A | 5.86 million | 7.86 million | 5.01 million |
Cansortium Inc (CNTMF) Chart:
Cansortium Inc (CNTMF) News:
Below you will find a list of latest news for Cansortium Inc (CNTMF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Cansortium Inc (CNTMF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Cansortium Inc (CNTMF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|